Clinical trial data suggests that postmenopausal women of above-average weight have an increased risk of breast cancer.
The percentage of patients with early stage breast cancer undergoing breast-conserving therapy (BCT) increased from 54.3% in 1998 to 60.1% in 2011, according to a recent report. Notably, nonclinical factors including socioeconomic demographics, insurance, and the distance patients must travel to treatment facilities persist as key barriers to the treatment.
Breast cancer patients with high levels of the protein activin-like receptor kinase (ALK1) in the blood vessels of their tumors were more likely to develop metastatic disease, according to a new study. This makes inhibition of the ALK1 pathway a possible new target for the treatment of metastatic breast cancer.
CHICAGO, IL—Functional subtyping with a multigene classifier resulted in 1 in 5 tumors being reclassified compared with conventional immunohistochemistry/fluorescent in situ hybridization (IHC/FISH) analysis. This study was presented at the 2015 American Society for Clinical Oncology (ASCO) Annual Meeting.
10% urea cream is superior to a newly introduced ointment containing various antioxidants at preventing hand-foot syndrome.
Randomized trial shows beneficial effect for yoga combined with meditation in breast cancer survivors.
The links between demographic, treatment, and socioeconomic factors and breast cancer survival were examined in a recent study.
Women diagnosed with breast cancer and treated with a one-week regimen of partial breast radiation after tumor removal saw no increase in cancer recurrence or difference in cosmetic outcomes.
The presence of extra body fat causes increased risk of diabetes and heart disease, and also increases the chances for breast cancer recurrence.
The discovery of an enzyme that facilitates the spread of breast cancer may enable clinicians to prevent secondary cancer.
Embryo cryopreservation after aromatase inhibitor treatment and ovarian stimulation preserves fertility for patients with breast cancer, according to a study published online.
Premenopausal women with breast cancer are at increased risk of dying if they smoke.
Expanded surgical margins during a partial mastectomy could be beneficial for patients, preventing further surgery.
The majority of women with early-stage breast cancer undergo imaging for metastatic cancer despite guidelines.
A false breast cancer diagnosis can have long-lasting psychological effects.
The number of patients that undergo breast-conserving therapy (BCT) has risen slowly in recent years, but many with early-stage disease still choose mastectomy.
Breast surgery performed at or shortly after a diagnosis of low-grade ductal carcinoma in-situ (DCIS) was not found to significantly impact patients' survival rate.
Rates of breast-conserving therapy for early-stage breast cancer have increased.
Poor sleep and snoring before breast cancer diagnosis is tied to poor survival outcomes.
Half of the women with breast cancer polled considered double mastectomy, but only a little more than a third knew the aggressive procedure doesn't up the chances of survival.
Women ages 50 to 69 years who attend mammography screening reduce their risk of dying from breast cancer by 40% compared with women who are not screened, according to the latest evidence.
A Norwegian breast cancer screening program has markedly reduced breast cancer mortality.
An increase in cases of male breast cancer to the growing list of cancers associated with rising obesity rates.
Obesity is associated with increased risk for invasive breast cancer in postmenopausal women.
A new research review indicates that breast screening in the 40s may not prevent breast cancer deaths, but the conclusion among researchers wasn't unanimous.
A new study found that prognosis after treatment for women with breast cancer with a family history of the disease is no worse than it is for other women with breast cancer.
Breast cancer patients are much less likely to have potentially lifesaving surgery if diagnosed as an emergency rather than via urgent GP referral.
Affordable Care Act has removed financial barriers to preventive services, including breast and colorectal cancer screening.
Adding palbociclib to standard hormone therapy may be more beneficial than hormone therapy alone for HR+/HER2− breast cancer, according to a new study.
Removing extra tissue can halve the chances of requiring a second surgery in breast cancer.
A blood test that involves examination of cell-free circulating DNA could be key to earlier detection of breast cancer metastases.
Breast surgery performed at or shortly after a diagnosis of low-grade ductal carcinoma in-situ (DCIS) experienced no difference in survival.
Depending on the type of cancer faced, the needs of survivors can vary.
Enzalutamide may be a viable alternative therapy over cytotoxic chemotherapy for individuals with triple-negative breast cancer, according to a study presented at the 2015 American Society of Clinical Oncology annual meeting.
Not all women with dense breasts have a high enough breast cancer risk to justify additional imaging after a normal mammogram, according to a recent study.
Early intervention should be offered to young women with breast cancer on ovarian function suppression and tamoxifen, who experience poorer quality of life (QOL) in the early survivorship period, according to a study presented at the 2015 American Society of Clinical Oncology Annual Meeting.
Letrozole significantly reduced the rate of late invasive breast cancer events in postmenopausal women who had completed 4+ years of adjuvant endocrine therapy for HR+ breast cancer, the LATER trial concluded at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting.
Outcome prediction for postmenopausal patients with node-positive HR+ early breast cancer can be improved using a diagnostic assay, potentially negating the need for adjuvant chemotherapy, according to a study presented at ASCO 2015.
Female breast cancer survivors may be able to lose weight through modest lifestyle changes.
New research indicates that men with naturally high levels of the female hormone estrogen may have a greater risk of developing breast cancer.
No difference seen in distant disease-free intervals for those with versus those without a positive family history, say researchers.
Women with luminal A subtype breast cancer, especially those older than 60 years, may not need radiation treatment if they are already taking hormone therapy.
A false breast cancer alarm may still result in severe psychological strain.
Magnetic resonance imaging (MRI) can provide vital information for predicting the odds of breast cancer development.
Low-income and women without insurance in states that are not expanding their Affordable Care Act (ACA) Medicaid coverage are less likely to receive breast and cervical cancer screenings.
Five-year risk plus breast density can best identify women at high risk for interval cancer.
Tomosynthesis detects 40% more breast cancers than traditional mammography does, according to a major screening study.
For women with breast cancer using the drug tamoxifen, coffee appears to both inhibit tumor growth and reduce recurrence.
Digital breast tomosynthesis increases the rate of cancer detection in women with dense breast tissue by as much as 67%, according to research.
A family history of breast cancer does not influence prognosis for women with breast cancer.
A new study reveals specific genetic alterations that appear to impact the prognosis and survival rates of African American women.
Slowly progressive weight lifting can reduce incidence of physical function deterioration.
Breast cancer that occurs in younger women is likely to be more aggressive and to require more intensive therapies, with increased risk of long-term side effects.
A majority of surgeon continue to recommend annual breast cancer screening for women in their forties, despite a 2009 US Preventive Services Task Force (USPSTF) recommendation that recommends otherwise.
Researchers have identified gene mutations associated with breast cancer onset in populations of Polish and French-Canadian women.
Chemotherapy, which can cause an inability to concentrate, is measurable effect related to cancer treatment.
Nearly a third of women eligible for breast-conserving therapy instead opt for removal of an entire breast.
Slowly progressive weight lifting reduced the incidence of physical function deterioration among breast cancer survivors.
Although FDG PET/CT is appropriate for systemic staging of newly diagnosed stage III breast cancer, the technique may not be equally valuable for all breast cancer histologies, research indicates.
Oophorectomy is linked to a 62% reduction in breast cancer death for women diagnosed with breast cancer that carry a BRCA1 gene mutation.
Many Americans are not getting recommended screening tests for breast, cervical, and colon cancers.
Sensor technology is used to illustrate the amount of pressure applied in breast palpation, helping clinicians refine their clinical skills for locating a breast mass.
South Asian women are more likely to have later stage breast cancer at diagnosis compared with the general population, research has shown.
Immediate treatment with zoledronic acid prevented bone loss compared with delayed treatment in breast cancer.
Survival mechanism in breast cancer cells is found to result in poorer outcomes for African American women
The worse outcomes for African American women with estrogen-receptor positive (ER+) breast cancer, when compared with European American patients, appears to be related to a reduced cellular sensitivity to tamoxifen.
Preliminary study results indicate that an experimental immune system drug is generally safe and well tolerated in women with metastatic, triple-negative breast cancer.
Researchers investigated the disparities between blacks and whites in receipt of treatment for early stage breast cancer.
Breast cancer and chemobrain: Stress of diagnosis can impair cognitive function before chemotherapy is started
Milder cognitive defects displayed by breast cancer patient even before the initiation of chemotherapy may be attributable to disease-related posttraumatic stress, new study data indicates.
Survival and recurrence rates show little difference in women who undergo full breast removal as opposed to retaining the nipple during the procedure.
For many women with breast cancer, there is concern about the genetic risk of developing other cancers themselves or of a loved one developing cancer.
Higher costs for breast cancer treatments are linked to better outcomes, according to a recent study.
Lowest variability seen in Volpara and Quantra; higher variability for Cumulus ABD and CumulusV methods.
Physicians and cancer survivors influence women undergoing bilateral mastectomy as their treatment for breast cancer.
Women diagnosed with breast cancer who previously breastfed their babies had a 30% overall decreased risk of disease recurrence.
There may be gaps in information and support provision after diagnosis for breast cancer.
Researchers have identified mutations that were associated with significantly different risks of breast and ovarian cancers, which may have implications for risk assessment and cancer prevention decision making among carriers of these mutations.
Although not usually recommended for women with localized cancer undergoing breast-conserving surgery, axillary lymph node evaluation is performed frequently in women with ductal carcinoma in situ (DCIS) breast cancer.
Four major themes characterize the experience of cancer risk management for women who are positive for BRCA genetic mutations.
A supervised, moderate- to high-intensity exercise program is most effective for patients with breast cancer undergoing adjuvant chemotherapy.
An analysis of the genetic data from more than 67,000 women has helped establish a polygenic risk score, derived from many genetic factors, which can be used to identify women with a greater breast cancer risk.
A large percentage of survivors of breast cancer have symptoms suggesting underlying sleep disorders that require referral.
New research has found that in women with early stage breast cancer, surgeons no longer universally remove most of the lymph nodes in the underarm area when a biopsy of the nearby lymph nodes indicates cancer.
Women in their 40s should make an informed personal decision, say the new draft guidelines.
The use of breast ultrasound could eliminate the need for biopsy in many cases in adolescent girls, according to a recent study.
Biennial (once every two years) screening is preferable for women of age 50 through 74 that have an average risk of developing breast cancer.
An increase in overnight fasting decreases glucose levels and may lower the risk of breast cancer among women.
An evaluation of this mobile health app found easy to use for diverse, low-income women.
Researchers have learned more about breast cancer, including identification of a gene that drives the aggressive disease.
Most hospitalists would not order an inpatient mammography for breast cancer screening.
Although many patients with breast cancer are concerned about genetic risk for other cancer types, almost half don't have conversation with doctor about potential for future problems.
A low degree of mammographic breast density worsens the prognosis of breast cancer, according to a recent study.
A text reminder can help increase breast cancer screening attendance, study data shows.
Specific BRCA mutations confer higher risks of breast cancer, while other BRCA mutations confer higher risks of ovarian cancer.
A recent study has determined that approximately 90 percent of breast cancers can be diagnosed via magnetic resonance imaging (MRI).
A third of women diagnosed with breast cancer are concerned about the genetic risk of a family member developing cancer.
A newly discovered mechanism that has helped researchers understand why some breast cancer tumors respond to specific chemotherapies and others do not.
Enabling patients to manage stress early in their breast cancer treatment can improve their mood and quality of life many years later.
Racial and ethnic differences extend to how surgeons and hospitals for breast cancer care are selected
Black and Hispanic women with breast cancer were less likely to use reputation as a factor ins selecting their surgeon or hospital for treatment, when compared with white women.
Breast cancer patients given the hormone-blocking drug goserelin during chemotherapy experience less ovarian failure and are more likely to have successful pregnancies, according to study results.
Women with diabetes may have an increased risk of being diagnosed with advanced breast cancer, according to new study results.
- Growing up with cancer: Understanding the challenges to adolescents and young adults (AYAs) coping with cancer
- Navigators have a key role in using genetics and genomics for cancer risk identification
- Using the navigation process to improve both your program and your patient outcomes
- Composing a CoC-compliant community health needs assessment (CHNA)
- Younger, unrelated donors with high T cell counts make better matches for patients undergoing stem cell transplant
- Survivorship care plans: The shift back to primary care
- Scientists identify key to preventing metastatic breast cancer
- Cancer and intimate partner violence: Could you tell if one of your patients is a victim?
- Blood test detects breast cancer metastasis early
- Composing a CoC-compliant community health needs assessment (CHNA)
- Comorbid conditions associated with worse lung cancer survival
- Benefits found for screening colonoscopies of higher quality
- High-grade cervical lesions declining in young women
- Early relapse of follicular lymphoma may increase risk of death
- Study identifies perception gap in incidence, impact of CINV/RINV
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|